10 results
Hypereosinophilia and Hypereosinophilic Syndrome

 • Secondary Hypereosinophilic Syndrome
 • Clinically Relevant HES Variants
 • When to
Hypereosinophilia and ... Treatment Algorithm ... #HES #Hematology ... eosinophils #diagnosis #management ... #algorithm
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... for VTE in Malignancy ... risk of recurrent VTE ... Anticoagulation #Management ... #Hematology #Oncology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... for the treatment ... Currently, edoxaban and ... Anticoagulation #Management ... #Hematology #Oncology
SAPHO Syndrome Summary

What?
SAPHO syndrome is a rare chronic inflammatory disorder of bone, joint, and skin characterized
anterior chest wall, parts ... lower jaw Treatment ... #Rheumatology # ... diagnosis #management ... #Dermatology
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease
 • Superficial Venous Thrombosis
 • Upper
post-thrombotic syndrome ... DeLoughery @Bloodman #VTE ... anticoagulation #duration #management ... #DVT #hematology ... #length #treatment
Gout - Diagnosis and Management Summary

3 Conditions for Gout to Manifest:
1. Hyperuricemia
2. Monosodium urate deposition in
Management Summary ... sex • Metabolic syndrome ... forefoot, ankles, knees ... , fingers, wrist ... #treatment #rheumatology
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Thromboembolism Treatment ... Algorithm Treat ... therapy - Second VTE ... #Algorithm #management ... #hematology #anticoagulation
There are similarities and differences between these 3 conditions which all carry treatment implications. Each mimic
which all carry treatment ... In both SK and AK ... for Refeeding Syndrome ... #differential #algorithm ... #management #treatment
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
system: small-fiber ... phenomenon (16%) MSK ... Adenocarcinoma Treatment ... #Rheumatology # ... Diagnosis #Management
Relapsing Polychondritis

What is it?
Recurrent inflammation of the cartilage in the body (Autoimmune disorder)

Who?
• Most frequently: 40
aorta) • Eyes • Inner ... polychondritis usually spares ... affected tissue Treatment ... Polychondritis #rheumatology ... #diagnosis #management